Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Overall Study	STARTED	Pitavastatin 2 mg QD	321
Overall Study	STARTED	Atorvastatin 10 mg QD	103
Overall Study	STARTED	Pitavastatin 4 mg QD	303
Overall Study	STARTED	Atorvastatin 20 mg QD	103
Overall Study	Safety Population	Pitavastatin 2 mg QD	316
Overall Study	Safety Population	Atorvastatin 10 mg QD	102
Overall Study	Safety Population	Pitavastatin 4 mg QD	300
Overall Study	Safety Population	Atorvastatin 20 mg QD	103
Overall Study	COMPLETED	Pitavastatin 2 mg QD	301
Overall Study	COMPLETED	Atorvastatin 10 mg QD	98
Overall Study	COMPLETED	Pitavastatin 4 mg QD	288
Overall Study	COMPLETED	Atorvastatin 20 mg QD	100
Overall Study	NOT COMPLETED	Pitavastatin 2 mg QD	20
Overall Study	NOT COMPLETED	Atorvastatin 10 mg QD	5
Overall Study	NOT COMPLETED	Pitavastatin 4 mg QD	15
Overall Study	NOT COMPLETED	Atorvastatin 20 mg QD	3

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00249249/flow